Effects of hormone therapy and dietary soy on myocardial ischemia/reperfusion injury in ovariectomized atherosclerotic monkeys

Menopause

Volumn 15, Issue 2, 2008, Pages 256-263

  Suparto, Irma H ^b   Williams, James Koudy ^a   Fox, Jamie L ^a   Yusuf, J Tuty L ^b   Sajuthi, Dondin ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

Atherosclerosis; Hormone therapy; Ischemia reperfusion; Monkeys; Myocardial; Soy

Indexed keywords

CASEIN; ETHINYLESTRADIOL; HORMONE; ISOFLAVONE DERIVATIVE; MALONALDEHYDE; MYELOPEROXIDASE; NORETHISTERONE ACETATE; SOYBEAN PROTEIN; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; FEMALE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HORMONE SUBSTITUTION; LIPID BLOOD LEVEL; NONHUMAN; OVARIECTOMY; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; SOYBEAN; STAINING;

ANIMALS; CORONARY ARTERY DISEASE; DIET, ATHEROGENIC; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ESTROGEN REPLACEMENT THERAPY; FEMALE; ISOFLAVONES; MACACA FASCICULARIS; MALONDIALDEHYDE; MENOPAUSE; OVARIECTOMY; PEROXIDASE; REPERFUSION INJURY; SOYBEAN PROTEINS;

EID: 40449133613     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31812e6b4a     Document Type: Article

References (45)

1. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer JM. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
3. Hodis HN, Mack WJ, Azen SP, et al, for the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535-545.
4. Rosenfeld ME, Kauser K, Martin-McNulty B, Polinsky P, Schwartz SM, Rubanyi GM. Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 2002;164:159-251.
5. Williams JK, Anthony MS, Honore EK, et al. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 1995;15:827-836.
6. Kreijkamp-Kapsers S, Kok L, Grobbee DE, et al. Effects of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004;292:65-74.
7. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 1997;46:698-705.
8. Williams JK, Anthony MS, Herrington DM. Interactive effects of soy protein and estradiol on coronary artery reactivity in atherosclerotic, ovariectomized monkeys. Menopause 2001;8:307-313.
9. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression - a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001;186:41-47.
10. Clarkson TB. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002;132:566S-569S.
11. Carden DK, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255-266.
12. Braunwald E, Kloner RA. Myocardial reperfusion: a double- edged sword. J Clin Invest 1985;76:1713-1719.
13. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999;43:860-878.
14. Lefer AM. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg 1995;60:847-851.
15. Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG, Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 2001;104:2300-2304.
16. Beer S, Reincke M, Kral M, et al. Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. J Cardiovasc Pharmacol 2002;40:420-428.
17. Squandrito F, Altavilla D, Squandrito G, et al. 17 β-Estradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol 1997;335:185-192.
18. Ji E, Yue H, Wu Y, He R. Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits. Acta Pharmacol Sin 2004;25:306-312.
19. Deodato B, Altavilla D, Squadrito G, et al. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol 1999;128:1690-1693.
20. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
21. US Department of Health, Education, and Welfare. Manual of Laboratory Operations: Lipid Research Clinics Program. Vol 1. Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart, Lung and Blood Institute, National Institutes of Health, 1974. Publication no. NIH 75-268.
22. Fossati P, Principe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-2080.
23. Suparto IH, Williams JK, Cline JM, Anthony MS, Fox JL. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. Am J Obstet Gynecol 2003;188:1132-1140.
24. Williams JK, Kim YD, Adams MR, Chen M-F, Myers AK, Ramwell PW. Effects of estrogen on cardiovascular responses of premenopausal monkeys. J Pharmacol Exp Ther 1994;271:671-676.
25. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;8:206-209.
26. Masini E, Cuzzocea S, Mazzon E, Marzocca C, Mannaioni PF, Salvemini D. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vitro. Br J Pharmacol 2002;136:905-917.
27. Suparto IH, Williams JK, Fox JL, Vinten-Johansen J. A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy. Coronary Artery Dis 2005;16:301-308.
28. Zhai P, Eurell TE, Cooke PS, Lubahn DB, Gross DR. Myocardial ischemia-reperfusion injury in estrogen receptor-α knockout and wild-type mice. Am J Physiol Heart Circ Physiol 2000;278:H1640-H1647.
29. Wood CE, Register TC, Franke AA, Anthony MS, Cline JM. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 2006;66:1241-1249.
30. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-154.
31. Liew R, Williams JK, Collins P, MacLeod KT. Soy-derived isoflavones exert opposing actions in guinea pig ventricular myocytes. J Pharmacol Exp Ther 2003;304:985-993.
32. Ravindranath MH, Muthugounder S, Presser N, Viswnathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004;546:121-165.
33. Mirkin S, Navarro F, Archer DF. Hormone therapy and endometrial angiogenesis. Climacteric 2003;6:273-277.
34. Lamping KG, Christensen LP, Tomanek RJ. Estrogen therapy induces collateral and microvascular remodeling. Am J Physiol Heart Circ Physiol 2003;285:H2039-H2044.
35. Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointimal formation. Circulation 2003;107:3059-3065.
36. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, Hurn DD. Estradiol regulates angiopeptin-1 mRNA expression through estrogen receptor-α in a rodent experimental stroke model. Stroke 2005;36:337-341.
37. Zaitseva M, Yue DS, Katzenellenbogen JA, Rogers PA, Gargett CE. Estrogen receptor-α agonists promote angiogenesis in human myometrial microvascular endothelial cells. J Soc Gynecol Investig 2004;11:529-535.
38. Shilkrut M, Yaniv G, Asleh R, Levy AP, Larisch S, Binah O. Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes. J Mol Cell Cardiol 2003;35:1229-1240.
39. Camper-Kirby D, Welch S, Walker A, et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 2001;88:1020-1027.
40. Rao PS, Cohen MV, Mueller HS. Production of free radicals and lipid peroxides in early experimental myocardial ischaemia. J Mol Cell Cardiol 1983;15:713-716.
41. Exner M, Hermann M, Hofbauer R, et al. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein. Free Radic Res 2001;34:101-112.
42. Vega-Lopez S, Yeum KJ, Lecker JL, et al. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr 2005;81:43-49.
43. Kim YD, Farhat MY, Myers AK, et al. 17-β Estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. J Cardiovasc Res 2000;46:20-23.
44. Xu Y, Armstrong SJ, Arenas IA, Pehowich DJ, Davidge ST. Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am J Physiol 2004;287:H165-H171.
45. Wood CE, Register TC, Anthony MS, Kock ND, Cline JM. Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. J Clin Endocrinol Metab 2004;89:3462-3468.